Immunotherapy-related hepatitis: real-world experience from a tertiary centre

<p><strong>Objective</strong> Immune checkpoint inhibitors like anti-programmed cell death protein 1 (PD-1) drugs Nivolumab and Pembrolizumab and anti-cytotoxic T-lymphocyte associated (CTLA-4) drug Ipilimumab have become standard of care in many metastatic cancers. Immunotherapy-r...

Full description

Bibliographic Details
Main Authors: Cheung, V, Gupta, T, Payne, M, Middleton, MR, Collier, JD, Simmons, A, Klenerman, P, Brain, O, Cobbold, JF
Format: Journal article
Published: BMJ Publishing Group 2019

Similar Items